RESCU System for Robust Upper Limb Prosthesis Control (RESCU)

April 23, 2024 updated by: Rahul Kaliki, Infinite Biomedical Technologies

User-driven Retrospectively Supervised Classification Updating (RESCU) System for Robust Upper Limb Prosthesis Control

This study will compare the use of RESCU [Experimental] Prosthesis with a [Standard] pattern recognition prosthesis in a clinical setting and in unsupervised daily activity. The protocol will follow a single case experimental design (SCED) to compensate for the limited size of the patient population. Each of the participants will use the Standard and Experimental and systems over a 35-day period. The Standard system will include at least two controllable DoFs (hand, wrist, multi-articulated hand, etc) and a commercially-available pattern recognition controller. The RESCU system will use the same components as the Standard system but will differ with respect to incorporating eight IBT Element Electrodes (as required for pattern recognition control) and the RESCU control software. The hypothesis is that pattern recognition will outperform the commercially-available control strategy for most participants on in-clinic, at-home usage, and subjective measures.

Study Overview

Status

Completed

Conditions

Detailed Description

The AB sequence for the study protocol is described below, where control type A is the Standard prosthesis and control type B is the Experimental prosthesis.

On Day 0, the participant will be evaluated with the Standard prosthesis. A series of Measures (as defined in the next paragraph) will then be recorded. The participant will then take the prosthesis home for one week, and daily use data will be recorded. The participant will return to the clinic for Day 7 Measures and download of the daily use data. During this session, the participant will be fit with the second system, undergo occupational therapy in the clinic, and Measures will be recorded. There will be no washout period as the prosthesis is expected to be in daily use. The participants will go home for a four-week period and return on Day 35 for a third set of Measures. At this time, the participant will be asked which prosthesis he/she prefers.

There are limited functional outcome assessment options for the planned comparison. However, the investigators will test functional measures at the clinic appointments, examine daily use data, and administer several qualitative surveys to assess participant outcomes.

Study Type

Interventional

Enrollment (Actual)

4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Silver Spring, Maryland, United States, 20910
        • Medical Center O&P

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Trans-radial limb difference.
  • Candidate for a 2+ degree-of-freedom (DoF) myoelectric pattern recognition prosthesis as determined by the study prosthetist
  • Active pattern recognition myoelectric prosthesis user
  • Fluent in English
  • Age of 18 years or greater

Exclusion Criteria:

  • Patients with a residual limb that is unhealed from the amputation surgery
  • Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes
  • Unhealed wounds
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems as judged by the project therapist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single-Case Experimental Design
Participants act as their own controls. They first use the Control device, which includes the pattern recognition controller, 8 electrodes, batteries, socket, frame, and prosthesis terminal device (hand/wrist/elbow). Participants are then transitioned to the Experimental device, which includes the RESCU controller, Apple iPad, 8 electrodes, batteries, socket, frame, and prosthesis terminal device (hand/wrist/elbow).
Retrospectively Supervised Classification Updating (RESCU) is founded on two innovations that promise significant improvement in performance and outcome. The first is a highly robust machine intelligence algorithm, an Extreme Learning Machine with Adaptive Sparse Representation (EASRC), and the second is a novel adaptive learning algorithm and communication interface we call Nessa. We contend that these two technologies allow the prosthetic device to adapt to its user from the initial fitting through continuing, long-term use in the activities of daily living, shifting the paradigm of training from the current prospective data gathering methods to a more dynamic retrospective application.
Pattern recognition prostheses associate the patterns of activity of multiple EMG sites to the action of a prosthesis. Such strategies have historically required prospective calibration of the EMG activation patterns.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Daily Prosthesis Use Duration
Time Frame: Baseline, 4 weeks
Prosthesis usage time was monitored as a proxy for user satisfaction, under the assumption that when an individual is more satisfied with their prosthetic solution, they will use it more in their daily lives. For the experimental intervention, the mean daily prosthesis use duration is reported as the average number of hours the prosthesis was used daily over the evaluation period (i.e., four weeks). For the control intervention, the mean daily prosthesis use duration is reported as the average number of hours the prosthesis was used daily before the evaluation period (i.e., at baseline).
Baseline, 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activities Measure for Upper Limb Amputees (AM-ULA)
Time Frame: Baseline, Post-Fitting, Post-Intervention
The AM-ULA is a clinician-graded measure of activity performance for adults with upper limb amputation that considers task completion, speed, movement quality, skillfulness of prosthetic use, and independence to quantify how functional an individual is while using their prosthesis. A higher score indicates overall greater prosthesis functionality.
Baseline, Post-Fitting, Post-Intervention
Orthotics and Prosthetics User's Survey Upper Extremity Functional Status (OPUS UEFS)
Time Frame: Baseline, Post-Intervention
The OPUS UEFS is a self-report questionnaire that asks respondents to score how easily they can complete several activities of daily living (e.g., drink from a paper cup, brush hair, etc.). A higher score indicates greater function.
Baseline, Post-Intervention
Trinity Amputation and Prosthesis Experience Survey for Upper Limb Amputation (TAPES-ULA)
Time Frame: Baseline, Post-Intervention
The Psychosocial Adjustment to Amputation measure (originally modified from the TAPES-ULA) is a self-report questionnaire that asks respondents to measure how well they have adapted to life with their amputation and prosthesis. This measure was administered specifically to quantify prosthesis use and return to work. The measure contains two subscales: a 7-item Adjustment to Limitation subscale and a 9-item Work and Independence subscale. For the Adjustment to Limitation subscale, a higher score indicates greater adjustment. For the Work and Independence subscale, a higher score indicates greater feelings of dependency.
Baseline, Post-Intervention
PROMIS Satisfaction Short Form 8a
Time Frame: Baseline, Post-Intervention
The PROMIS Satisfaction Short Form 8a is a self-report questionnaire designed to query individuals on their satisfaction with their ability to participate in social roles and activities. This measure was chosen due to its ability to capture patient satisfaction with their ability to participate in activities of daily living throughout various roles in life. A higher score indicates higher satisfaction with their ability to participate in work and home life.
Baseline, Post-Intervention
Pain Scale
Time Frame: Baseline, Post-Fitting, Post-Intervention
Participants were queried about their experience of pain, both in their residual limb and in their phantom limb perception to detect if the choice of control strategy affects pain levels. From 0 to 10, a higher score indicates more feelings of pain.
Baseline, Post-Fitting, Post-Intervention
Socket Comfort Score
Time Frame: Baseline, Post-Fitting, Post-Intervention
Socket comfort score was collected to determine if outside factors (i.e., socket fit) are affecting function during the take-home period.
Baseline, Post-Fitting, Post-Intervention
Range of Motion (of Residual Joints)
Time Frame: Baseline, Post-Fitting
The range of motion of the residual joints is an important factor when judging how well a prosthesis fits a participant, with a higher joint range of motion indicating a better fitting socket. For the individuals in this study (i.e., those with below-elbow amputations), the elbow range-of-motion is expected to be most affected by a prosthesis socket with a poor fit.
Baseline, Post-Fitting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2023

Primary Completion (Actual)

December 19, 2023

Study Completion (Actual)

December 19, 2023

Study Registration Dates

First Submitted

July 31, 2019

First Submitted That Met QC Criteria

July 31, 2019

First Posted (Actual)

August 2, 2019

Study Record Updates

Last Update Posted (Actual)

April 24, 2024

Last Update Submitted That Met QC Criteria

April 23, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • U44NS108894 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Subscribe